Literature DB >> 11231942

Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis.

R A Bras-Gonçalves1, M Pocard, J L Formento, F Poirson-Bichat, G De Pinieux, I Pandrea, F Arvelo, G Ronco, P Villa, A Coquelle, G Milano, T Lesuffleur, B Dutrillaux, M F Poupon.   

Abstract

BACKGROUND & AIMS: Butyrate, produced in the colon lumen, maintains mucosal cell homeostasis. Poorly diffusible, its access is compromised in growing colon cancers and absent in distant metastases. Butyrate regulates DNA synthesis. We postulated that systemic administration of butyrate should reduce colon cancer growth and enhance 5-fluorouracil (5-FU) efficacy.
METHODS: A stable derivative of butyrate (3n-But) was used. The antitumoral efficacy of 5-FU and 3n-But, alone or combined, was evaluated in human colorectal cancers (hCRCs) subcutaneously, orthotopically, or intrasplenically grafted into nude mice. Thymidylate synthase (TS) and thymidine kinase (TK) mRNA expression, proliferation, apoptosis, and cell cycle alterations were studied.
RESULTS: In vivo, 5-FU alone inhibited growth of only 3 of the 12 hCRCs tested and 3n-But alone had no effect; the 5-FU/3n-But combination inhibited growth of all 16 hCRCs tested. The hCRCs differed in their p53 and microsatellite instability status. 5-FU/3n-But decreased TK and TS mRNA expression by 20- and 40-fold, respectively, and TS activity by 75%, stopped cell proliferation without affecting cell differentiation, and significantly enhanced apoptosis. 3n-But potentiated the efficacy of Tomudex and methotrexate, 2 TS inhibitors, but not that of oxaliplatin. In vitro, 5-FU/3n-But inhibited [3H]thymidine but not bromodeoxyuridine incorporation and induced apoptosis in hCRC cell lines. Cells treated with 5-FU/3n-But did not accumulate in G1 nor in S phase of the cell cycle, while 5-FU and 3n-But arrested the cycle in S and in G1 phase, respectively. 3n-But prevented the cell rescue from 5-FU-induced cytotoxicity by uridine or thymidine.
CONCLUSIONS: 3n-But and TS inhibitors acted synergistically against colorectal cancers, independently of the genetic alterations of the hCRCs. The mechanism of action of 5-FU/3n-But could be enhanced reduction of TS and prevention of thymidine salvage in DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231942     DOI: 10.1053/gast.2001.22440

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  13 in total

1.  Less cytotoxicity to combination therapy of 5-fluorouracil and cisplatin than 5-fluorouracil alone in human colon cancer cell lines.

Authors:  Xiu-Xu Chen; Mao-De Lai; Yong-Liang Zhang; Qiong Huang
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

2.  RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cells.

Authors:  Atsushi Naito; Hirofumi Yamamoto; Yoshinori Kagawa; Yoko Naito; Daisuke Okuzaki; Keisuke Otani; Yoriko Iwamoto; Sakae Maeda; Junichi Kikuta; Keizo Nishikawa; Mamoru Uemura; Junichi Nishimura; Taishi Hata; Ichiro Takemasa; Tsunekazu Mizushima; Hideshi Ishii; Yuichiro Doki; Masaki Mori; Masaru Ishii
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

3.  Diet, Gut Microbiota, and Colorectal Cancer Prevention: A Review of Potential Mechanisms and Promising Targets for Future Research.

Authors:  Mingyang Song; Andrew T Chan
Journal:  Curr Colorectal Cancer Rep       Date:  2017-09-04

Review 4.  Regulation of colonic epithelial butyrate transport: Focus on colorectal cancer.

Authors:  Pedro Gonçalves; Fátima Martel
Journal:  Porto Biomed J       Date:  2016-07-01

5.  Fiber Intake and Survival After Colorectal Cancer Diagnosis.

Authors:  Mingyang Song; Kana Wu; Jeffrey A Meyerhardt; Shuji Ogino; Molin Wang; Charles S Fuchs; Edward L Giovannucci; Andrew T Chan
Journal:  JAMA Oncol       Date:  2018-01-01       Impact factor: 31.777

Review 6.  The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer.

Authors:  Janindra Warusavitarne; Margaret Schnitzler
Journal:  Int J Colorectal Dis       Date:  2006-11-16       Impact factor: 2.796

7.  Chemotherapy response evaluation in a mouse model of gastric cancer using intravoxel incoherent motion diffusion-weighted MRI and histopathology.

Authors:  Jin Cheng; Yi Wang; Chun-Fang Zhang; He Wang; Wei-Zhen Wu; Feng Pan; Nan Hong; Jie Deng
Journal:  World J Gastroenterol       Date:  2017-03-21       Impact factor: 5.742

8.  Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice.

Authors:  P Leuraud; L Taillandier; L Aguirre-Cruz; J Medioni; E Crinière; Y Marie; A M Dutrillaux; M Kujas; A Duprez; J-Y Delattre; M-F Poupon; M Sanson
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

9.  Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil.

Authors:  B S Vinod; J Antony; H H Nair; V T Puliyappadamba; M Saikia; S Shyam Narayanan; A Bevin; R John Anto
Journal:  Cell Death Dis       Date:  2013-02-21       Impact factor: 8.469

Review 10.  Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer.

Authors:  Cong-Min Zhang; Jin-Feng Lv; Liang Gong; Lin-Yu Yu; Xiao-Ping Chen; Hong-Hao Zhou; Lan Fan
Journal:  Int J Environ Res Public Health       Date:  2016-09-08       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.